🇧🇷 Chapter 30 — Pharmaceutical Products Trade with Brazil
Export and import data for Indian businesses
$486.8M
Exports to Brazil (2024)
$120.5M
Imports from Brazil (2024)
6
HS Headings Traded
🇧🇷 Brazil — Country Profile
Capital
Brasilia
GDP (USD)
$2K
Population
215.3M
Currency
Real
Trade Agreement
No preferential agreement
HS Heading Breakdown — Chapter 30
| HS Code | Description | Export (USD) | Import (USD) |
|---|---|---|---|
| 3004 | Medicaments (excluding Goods Of Heading 3002, 3005 Or 3006) Consisting Of Mixed Or Unmixed Products For Therapeutic Or Prophylactic Uses, Put Up In Measured Doses (including Those In The Form Of Transdermal Administration Systems) Or In Forms Or Packings | $364.9M | $115.8M |
| 3002 | Human Blood; Animal Blood Prepared Fortherapeutic, Prophylactic Or Diagnostic Uses; Antisera, Other Blood Fractions And Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines,toxins, Cultures Of Micro- | $90.0M | $2.1M |
| 3003 | Medicaments (excluding Goods Of Heading 3002, 3005 Or 3006) Consisting Of Two Or More Constituents Which Have Been Mixed Together For Therapeutic Or Prophylactic Uses, Not Put Up In Measured Doses Or In Forms Or Packings For Retail Sale | $27.5M | $40K |
| 3006 | Pharmaceutical goods specified in note 4 to this chapter | $3.0M | $1.9M |
| 3005 | Wadding, Gauze, Bandages And Similar Articles (for Example, Dressings, Adhesive Plasters, Poultices), Impregnated Or Coated With Pharmaceutical Substances Or Put Up In Forms Or Packings For Retail Sale For Medical, Surgical, Dental Or Veterinary Purposes | $1.4M | $475 |
| 3001 | Glands And Other Organs For Organo- Therapeutic Uses, Dried,whether Or Not Powdered; Extracts Of Glands Or Other Organs Or Of Their Secretions For Organo- Therapeutic Uses; Heparin And Its Salts; Other Human Or Animal Substances Prepared For Therapeutic O | $475 | $700K |
Other Trading Partners for Chapter 30
Trade in Pharmaceutical Products with Brazil
Get detailed market intelligence and export guidance.